ERN1 and myeloid sarcoma: Furthermore, another study aimed at identifying signaling pathways involved in pathogenic neuroinflammation in multiple sclerosis (MS), revealed that IRE1α/XBP1 signaling in astrocytes is a driver of genomic programs and that it modulates astrocyte pro-inflammatory activities (170).